Diabetes Mellitus, Type 2

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Sacramento, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Santa Ana, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Jacksonville, Florida, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Miami, Florida, United States

• UT Southwestern Medical Center — Dallas, Texas, United States
• UT Southwestern — Dallas, Texas, United States

• University of Maryland, Baltimore — Baltimore, Maryland, United States

• Univerisity of Maryland, Baltimore — Baltimore, Maryland, United States

• Investigational Site Number 840731 — Birmingham, Alabama, United States
• Investigational Site Number 840305 — Birmingham, Alabama, United States
• Investigational Site Number 840811 — Birmingham, Alabama, United States
• Investigational Site Number 840218 — Gulf Shores, Alabama, United States

Not specified

• Diabetes Research Center — Boston, Massachusetts, United States

• Nemours Children's Health System — Jacksonville, Florida, United States

• Rigshospitalet, Denmark — Copenhagen, Capital Region, Denmark

• Multiple Locations, Japan